Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 034039/0796 | |
| Pages: | 5 |
| | Recorded: | 10/23/2014 | | |
| Attorney Dkt #: | 2030.1003US, PCT, USCON |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPL. NO. 13/737,034 PREVIOUSLY RECORDED AT REEL: 033848 FRAME: 0786. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/29/2014
|
Application #:
|
13437034
|
Filing Dt:
|
04/02/2012
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2012
| | | | |
|
Title:
|
ENGINEERED NUCLEIC ACIDS ENCODING A MODIFIED ERYTHROPOIETIN AND THEIR EXPRESSION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13897362
|
Filing Dt:
|
05/18/2013
|
|
Publication #:
|
|
Pub Dt:
|
09/19/2013
| | | | |
|
Title:
|
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF FACTOR IX
|
|
|
Assignee
|
|
|
|
|
| 200 TECHNOLOGY SQUARE |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
Correspondence name and address
|
| |
DT WARD, PC
|
| |
142A MAIN STREET
|
| |
GROTON, MA 01450
|
Search Results as of:
06/14/2024 01:35 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
